Nerve problems can create dry eye symptoms

Article

LASIK patients who make complaints symptomatic of dry eye may be suffering not from dry eye but from damaged, aberrantly regenerating nerve cells, said Timo Tervo.

LASIK patients who make complaints symptomatic of dry eye may be suffering not from dry eye but from damaged, aberrantly regenerating nerve cells, said Timo Tervo.

Dr Tervo noted that patient-reported symptoms in dry eye questionnaires do not correlate well with subsequent dry eye tests. The phenomenon can be seen when a patient complains of dry eye-like symptoms but both objective tests and the corneal mechanical threshold is normal.

Nerves are damaged following PRK or LASIK and if the sensory protective reflex arch is interrupted it can lead to dry eye. But damaged nerves also evoke abnormal sensations that may resemble dry eye. Dr Tervo cited a study that demonstrated neurotropic keratitis (Bonini et al. Eye 2003) resembles LASIK-induced neurotropic epitheliopathy (LINE).

The issue is important because dry eye is very frequent following a LASIK procedure and is a major cause of patient dissatisfaction. The cornea has the richest nerve supply, over 40 times richer than tooth pulp and 400 times richer than skin. Surgery interrupts the cornea-trigeminal nerve-brain stem-lacrimal gland reflex arch and nerve regeneration starts. Aberrant nerve regeneration may create fake 'dry eye' symptoms.

"Why is it painful?" Dr Tervo asked. Loose epithelium stretches the nerves when blinking or during eye opening, and there is often irregular epithelium. Microtrauma may also be a cause.

Dr Tervo concluded that it is vital to manage preoperative dry eye for LASIK. It can provide more reliable photoablation, less postoperative dry eye symptoms, more accurate preoperative refraction and wavefront analysis and better postoperative visual quality.

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.